BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

DOV Pharmaceutical 

Continental Plaza
433 Hackensack Avenue
Hackensack  New Jersey  07601  U.S.A.
Phone: 201-968-0980 Fax:


SEARCH JOBS


Industry
Pharmaceutical


Collaborations

Merck & Co., Inc.  Depression





 Company News
Euthymics Bioscience, Inc. Closes $24 Million Series A Financing and Completes Acquisition of DOV Pharmaceutical 7/22/2010 6:32:38 AM    More...
Euthymics Bioscience, Inc. and DOV Pharmaceutical Announce Merger Agreement 7/1/2010 7:09:04 AM    More...
Euthymics Bioscience, Inc. Announces Letter of Intent for Acquisition of DOV Pharmaceutical 2/12/2010 11:00:10 AM    More...
DOV Pharmaceutical Announces Successful Restructuring of Office Lease 3/4/2008 10:21:20 AM    More...
DOV Pharmaceutical Announces Third Quarter Results 11/7/2007 2:23:08 PM    More...
DOV Pharmaceutical to Present at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference 11/5/2007 12:10:21 PM    More...
DOV Pharmaceutical DOV 21,947 Demonstrates Significant Body Weight and BMI Reductions in Drug- Compliant Subjects in Phase Ib Clinical Study 9/25/2007 7:49:22 AM    More...
DOV Pharmaceutical Begins Trading on OTC Bulletin Board 8/29/2007 8:28:00 AM    More...
DOV Pharmaceutical Announces Successful Phase Ib Results for DOV 21,947 8/9/2007 11:01:25 AM    More...
DOV Pharmaceutical Announces Second Quarter 2007 Results 8/9/2007 9:27:16 AM    More...
12345678910...

//-->